Personas / Equipo Humano

Marta Giralt Oms

Buscador de publicaciones

Publicaciones

  • Domingo P, Fernández Carasa I, Gallego-Escuredo JM, Torres F, Gutierrez MDM, Mateo MG, Villarroya-Terrade J, Giralt M, Vidal F, Villarroya-Gombau F and Domingo JC.

    Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.

    CLINICAL NUTRITION . 37(4): 1340-1347. Nº de citas: 5

    [doi:10.1016/j.clnu.2017.05.032]

  • Moure R, Domingo P, Villarroya-Terrade J, Gasa L, Gallego-Escuredo JM, Quesada T, Morón-Ros S, Maroto AF, Mateo GM, Domingo JC, Villarroya-Gombau F and Giralt M.

    Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/ß-Klotho System.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 62(6): . Nº de citas: 11

    [doi:10.1128/AAC.00029-18]

  • Rupérez CH, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M, Villarroya-Terrade J, Giralt M, Villarroya-Gombau F and Planavila A.

    Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 260: 163-170. Nº de citas: 39

    [doi:10.1016/j.ijcard.2018.02.109]

  • Domingo P, Gallego-Escuredo JM, Fernández I, Villarroya-Terrade J, Torres F, Del Mar Gutierrez M, Mateo MG, Villarroya-Gombau F, Vidal F, Giralt M and Domingo JC.

    Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study.

    Cytokine . 105: 73-79. Nº de citas: 15

    [doi:10.1016/j.cyto.2018.02.008]

  • Villarroya-Gombau F, Gavaldà-Navarro A, Peyrou M, Villarroya-Terrade J and Giralt M.

    The Lives and Times of Brown Adipokines.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 28(12): 855-867. Nº de citas: 70

    [doi:10.1016/j.tem.2017.10.005]

  • Redondo-Angulo I, Mas-Stachurska A, Sitges M, Tinahones FJ, Giralt M, Villarroya-Gombau F and Planavila A.

    Fgf21 is required for cardiac remodeling in pregnancy.

    CARDIOVASCULAR RESEARCH . 113(13): 1574-1584. Nº de citas: 32

    [doi:10.1093/cvr/cvx088]

  • Gallego-Escuredo JM, Lamarca MK, Villarroya-Terrade J, Domingo JC, Mateo MG, Gutierrez MDM, Vidal F, Villarroya-Gombau F, Domingo P and Giralt M.

    High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 71: 163-170. Nº de citas: 15

    [doi:10.1016/j.metabol.2017.03.014]

  • Villarroya-Gombau F, Peyrou M and Giralt M.

    Transcriptional regulation of the uncoupling protein-1 gene.

    Biochimie . 134: 86-92. Nº de citas: 84

    [doi:10.1016/j.biochi.2016.09.017]

  • Giralt M and Villarroya-Gombau F.

    Mitochondrial Uncoupling and the Regulation of Glucose Homeostasis.

    Current Diabetes Reviews . 13(4): 386-394. Nº de citas: 33

    [doi:10.2174/1573399812666160217122707]

  • Soler J, Ferentinos P, Prats C, Miret S, Giralt M, Peralta V, Fañanás L and Fatjó-Vilas M.

    Familial aggregation of schizotypy in schizophrenia-spectrum disorders and its relation to clinical and neurodevelopmental characteristics.

    JOURNAL OF PSYCHIATRIC RESEARCH . 84: 214-220. Nº de citas: 11

    [doi:10.1016/j.jpsychires.2016.09.026]